
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
miR-125a-5p-abundant exosomes derived from mesenchymal stem cells suppress chondrocyte degeneration via targeting E2F2 in traumatic osteoarthritis
Qingqing Xia, Quan Wang, Feng Lin, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 11225-11238
Open Access | Times Cited: 50
Qingqing Xia, Quan Wang, Feng Lin, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 11225-11238
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Current Knowledge and Future Perspectives of Exosomes as Nanocarriers in Diagnosis and Treatment of Diseases
Zaijun Zou, Li Han, Gang Xu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4751-4778
Open Access | Times Cited: 43
Zaijun Zou, Li Han, Gang Xu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4751-4778
Open Access | Times Cited: 43
Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis
Danni Luo, Hao Zhu, Song Li, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 17
Danni Luo, Hao Zhu, Song Li, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 17
Engineering of MSC-Derived Exosomes: A Promising Cell-Free Therapy for Osteoarthritis
Jin Cheng, Yixin Sun, Yong Ma, et al.
Membranes (2022) Vol. 12, Iss. 8, pp. 739-739
Open Access | Times Cited: 39
Jin Cheng, Yixin Sun, Yong Ma, et al.
Membranes (2022) Vol. 12, Iss. 8, pp. 739-739
Open Access | Times Cited: 39
Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells
Giuliana Minani Bertolino, Marie Maumus, Christian Jørgensen, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 11, pp. 682-694
Closed Access | Times Cited: 30
Giuliana Minani Bertolino, Marie Maumus, Christian Jørgensen, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 11, pp. 682-694
Closed Access | Times Cited: 30
Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis
Anupama Vadhan, Tanvi Gupta, Wen‐Li Hsu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9149-9149
Open Access | Times Cited: 9
Anupama Vadhan, Tanvi Gupta, Wen‐Li Hsu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9149-9149
Open Access | Times Cited: 9
Potential and challenges of utilizing exosomes in osteoarthritis therapy (Review)
Xuesong Chen, Bin Tian, Yiqun Wang, et al.
International Journal of Molecular Medicine (2025) Vol. 55, Iss. 3
Closed Access | Times Cited: 1
Xuesong Chen, Bin Tian, Yiqun Wang, et al.
International Journal of Molecular Medicine (2025) Vol. 55, Iss. 3
Closed Access | Times Cited: 1
Extracecellulr vesicles (EVs) microRNAs (miRNAs) derived from mesenchymal stem cells (MSCs) in osteoarthritis (OA); detailed role in pathogenesis and possible therapeutics
Seyede Sara Pakdaman Kolour, Saeide Nematollahi, Masoud Dehbozorgi, et al.
Heliyon (2025), pp. e42258-e42258
Open Access | Times Cited: 1
Seyede Sara Pakdaman Kolour, Saeide Nematollahi, Masoud Dehbozorgi, et al.
Heliyon (2025), pp. e42258-e42258
Open Access | Times Cited: 1
Immunomodulatory and Regenerative Effects of MSC-Derived Extracellular Vesicles to Treat Acute GVHD
Sumie Fujii, Yasuo Miura
Stem Cells (2022) Vol. 40, Iss. 11, pp. 977-990
Closed Access | Times Cited: 29
Sumie Fujii, Yasuo Miura
Stem Cells (2022) Vol. 40, Iss. 11, pp. 977-990
Closed Access | Times Cited: 29
Conditioned Medium – Is it an Undervalued Lab Waste with the Potential for Osteoarthritis Management?
Monika A. Rosochowicz, Michał Lach, Magdalena Richter, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 5, pp. 1185-1213
Open Access | Times Cited: 17
Monika A. Rosochowicz, Michał Lach, Magdalena Richter, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 5, pp. 1185-1213
Open Access | Times Cited: 17
Unlocking the potential of exosomes: a breakthrough in the theranosis of degenerative orthopaedic diseases
Yaohang Yue, Wei Dai, Yihao Wei, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 6
Yaohang Yue, Wei Dai, Yihao Wei, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 6
Control of articular degeneration by extracellular vesicles from stem/stromal cells as a potential strategy for the treatment of osteoarthritis
María José Alcaraz
Biochemical Pharmacology (2024) Vol. 228, pp. 116226-116226
Open Access | Times Cited: 6
María José Alcaraz
Biochemical Pharmacology (2024) Vol. 228, pp. 116226-116226
Open Access | Times Cited: 6
Therapeutics of the future: Navigating the pitfalls of extracellular vesicles research from an osteoarthritis perspective
Antoine Karoichan, Sarah Boucenna, Maryam Tabrizian
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 6
Antoine Karoichan, Sarah Boucenna, Maryam Tabrizian
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 6
Nanodevices for deep cartilage penetration
Xiaoling Xu, Yan Xue, Jia-Ying Ding, et al.
Acta Biomaterialia (2022) Vol. 154, pp. 23-48
Closed Access | Times Cited: 27
Xiaoling Xu, Yan Xue, Jia-Ying Ding, et al.
Acta Biomaterialia (2022) Vol. 154, pp. 23-48
Closed Access | Times Cited: 27
Exosomes from miR-374a-5p-modified mesenchymal stem cells inhibit the progression of renal fibrosis by regulating MAPK6/MK5/YAP axis
Mingzhu Liang, Di Zhang, Danna Zheng, et al.
Bioengineered (2022) Vol. 13, Iss. 2, pp. 4517-4527
Open Access | Times Cited: 24
Mingzhu Liang, Di Zhang, Danna Zheng, et al.
Bioengineered (2022) Vol. 13, Iss. 2, pp. 4517-4527
Open Access | Times Cited: 24
Exosomes treating osteoarthritis: hope with challenge
Congxiao Wu, Yunfan He, Yao Yao, et al.
Heliyon (2023) Vol. 9, Iss. 1, pp. e13152-e13152
Open Access | Times Cited: 15
Congxiao Wu, Yunfan He, Yao Yao, et al.
Heliyon (2023) Vol. 9, Iss. 1, pp. e13152-e13152
Open Access | Times Cited: 15
Advances in the Study of Exosomes as Drug Delivery Systems for Bone-Related Diseases
Jiawen Huang, Yang Xu, Yuxuan Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 220-220
Open Access | Times Cited: 11
Jiawen Huang, Yang Xu, Yuxuan Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 220-220
Open Access | Times Cited: 11
Direct and cell-mediated EV-ECM interplay
Olga Smirnova, Yuri M. Efremov, Timofey O. Klyucherev, et al.
Acta Biomaterialia (2024) Vol. 186, pp. 63-84
Closed Access | Times Cited: 4
Olga Smirnova, Yuri M. Efremov, Timofey O. Klyucherev, et al.
Acta Biomaterialia (2024) Vol. 186, pp. 63-84
Closed Access | Times Cited: 4
Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases
M. Zubair, Fatma A. Abouelnazar, Muhammad Asad Iqbal, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
M. Zubair, Fatma A. Abouelnazar, Muhammad Asad Iqbal, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Mesenchymal stromal/stem cell-derived exosomes as a potential therapeutic approach to osteoarthritis combined with type 2 diabetes mellitus
Siyi Xie, Meiling Liu, Ya‐Jie Kong, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Siyi Xie, Meiling Liu, Ya‐Jie Kong, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Quercetin-primed MSC exosomes synergistically attenuate osteoarthritis progression
Mingfeng Lu, Aiju Lou, Junqing Gao, et al.
Journal of Orthopaedic Surgery and Research (2025) Vol. 20, Iss. 1
Open Access
Mingfeng Lu, Aiju Lou, Junqing Gao, et al.
Journal of Orthopaedic Surgery and Research (2025) Vol. 20, Iss. 1
Open Access
Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression
Yang Liu, Mingzhuang Hou, Zejun Pan, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Yang Liu, Mingzhuang Hou, Zejun Pan, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17
MSC-EV therapy for bone/cartilage diseases
Joe Kodama, Kevin J. Wilkinson, Satoru Otsuru
Bone Reports (2022) Vol. 17, pp. 101636-101636
Open Access | Times Cited: 16
Joe Kodama, Kevin J. Wilkinson, Satoru Otsuru
Bone Reports (2022) Vol. 17, pp. 101636-101636
Open Access | Times Cited: 16
Emerging functions and clinical applications of exosomal microRNAs in diseases
Soudeh Ghafouri‐Fard, Hamed Shoorei, Peixin Dong, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 3, pp. 350-362
Open Access | Times Cited: 10
Soudeh Ghafouri‐Fard, Hamed Shoorei, Peixin Dong, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 3, pp. 350-362
Open Access | Times Cited: 10
Exosomes Derived from Quercetin-Treated Bone Marrow Derived Mesenchymal Stem Cells Inhibit the Progression of Osteoarthritis Through Delivering miR-124-3p to Chondrocytes
Shiyu Dong, Genrong Xu, Xiaoliang Li, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 2, pp. 85-94
Closed Access | Times Cited: 3
Shiyu Dong, Genrong Xu, Xiaoliang Li, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 2, pp. 85-94
Closed Access | Times Cited: 3
Strategies in product engineering of mesenchymal stem cell-derived exosomes: unveiling the mechanisms underpinning the promotive effects of mesenchymal stem cell-derived exosomes
Yudong Jiang, Hanning Lv, Fuguo Shen, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 3
Yudong Jiang, Hanning Lv, Fuguo Shen, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 3